GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharmagreen Biotech Inc (OTCPK:PHBI) » Definitions » Pretax Margin %

Pharmagreen Biotech (Pharmagreen Biotech) Pretax Margin % : -16,300.00% (As of Jun. 2023)


View and export this data going back to 2008. Start your Free Trial

What is Pharmagreen Biotech Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Pharmagreen Biotech's Pre-Tax Income for the three months ended in Jun. 2023 was $-0.16 Mil. Pharmagreen Biotech's Revenue for the three months ended in Jun. 2023 was $0.00 Mil. Therefore, Pharmagreen Biotech's pretax margin for the quarter that ended in Jun. 2023 was -16,300.00%.

The historical rank and industry rank for Pharmagreen Biotech's Pretax Margin % or its related term are showing as below:

PHBI' s Pretax Margin % Range Over the Past 10 Years
Min: -25000   Med: 0   Max: 0
Current: -25000


PHBI's Pretax Margin % is ranked worse than
99.02% of 1019 companies
in the Drug Manufacturers industry
Industry Median: 4.27 vs PHBI: -25000.00

Pharmagreen Biotech Pretax Margin % Historical Data

The historical data trend for Pharmagreen Biotech's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmagreen Biotech Pretax Margin % Chart

Pharmagreen Biotech Annual Data
Trend Apr08 Apr09 Sep18 Sep19 Sep20 Sep21 Sep22
Pretax Margin %
Get a 7-Day Free Trial - - - - -

Pharmagreen Biotech Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - -18,800.00 -16,300.00

Competitive Comparison of Pharmagreen Biotech's Pretax Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Pharmagreen Biotech's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharmagreen Biotech's Pretax Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pharmagreen Biotech's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Pharmagreen Biotech's Pretax Margin % falls into.



Pharmagreen Biotech Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Pharmagreen Biotech's Pretax Margin for the fiscal year that ended in Sep. 2022 is calculated as

Pretax Margin=Pre-Tax Income (A: Sep. 2022 )/Revenue (A: Sep. 2022 )
=-0.876/0
= %

Pharmagreen Biotech's Pretax Margin for the quarter that ended in Jun. 2023 is calculated as

Pretax Margin=Pre-Tax Income (Q: Jun. 2023 )/Revenue (Q: Jun. 2023 )
=-0.163/0.001
=-16,300.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pharmagreen Biotech  (OTCPK:PHBI) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Pharmagreen Biotech Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Pharmagreen Biotech's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmagreen Biotech (Pharmagreen Biotech) Business Description

Traded in Other Exchanges
N/A
Address
112 North Curry Street, Carson, NV, USA, 89703
Pharmagreen Biotech Inc is a biotech science company with specialized products and services in the cannabis industry. The company plans to produce and sell tissue culture plantlets and cannabis oil. Its line of nutraceutical products is a proprietary blend of therapeutic plants and mushrooms. It is developing its business model beyond just cannabis, and is focused on near term revenues from its proprietary blend of therapeutic plants and fungi, a nutraceutical wellness product. Utilizing the Company's expertise in plant genetics, Its transgenic program uses the newest technology available to research and create nutraceuticals, protein-based vaccines, and daily supplements with the potential to improve lives and address a wide variety of disease conditions.